These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25816760)

  • 1. The bacteriocin AS-48 requires dimer dissociation followed by hydrophobic interactions with the membrane for antibacterial activity.
    Cebrián R; Martínez-Bueno M; Valdivia E; Albert A; Maqueda M; Sánchez-Barrena MJ
    J Struct Biol; 2015 May; 190(2):162-72. PubMed ID: 25816760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of a class IIb bacteriocin with a model lipid bilayer, investigated through molecular dynamics simulations.
    Kyriakou PK; Ekblad B; Kristiansen PE; Kaznessis YN
    Biochim Biophys Acta; 2016 Apr; 1858(4):824-35. PubMed ID: 26774214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of replacing glutamic residues upon the biological activity and stability of the circular enterocin AS-48.
    Sánchez-Hidalgo M; Martínez-Bueno M; Fernández-Escamilla AM; Valdivia E; Serrano L; Maqueda M
    J Antimicrob Chemother; 2008 Jun; 61(6):1256-65. PubMed ID: 18385141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of mesentericin y105, an anti-Listeria bacteriocin, for determination of impact on bactericidal activity, in vitro secondary structure, and membrane interaction.
    Morisset D; Berjeaud JM; Marion D; Lacombe C; Frère J
    Appl Environ Microbiol; 2004 Aug; 70(8):4672-80. PubMed ID: 15294801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and three-dimensional structure of carnobacteriocin XY, a class IIb bacteriocin produced by Carnobacteria.
    Acedo JZ; Towle KM; Lohans CT; Miskolzie M; McKay RT; Doerksen TA; Vederas JC; Martin-Visscher LA
    FEBS Lett; 2017 May; 591(10):1349-1359. PubMed ID: 28391617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriocin AS-48 binding to model membranes and pore formation as revealed by coarse-grained simulations.
    Cruz VL; Ramos J; Melo MN; Martinez-Salazar J
    Biochim Biophys Acta; 2013 Nov; 1828(11):2524-31. PubMed ID: 23756777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, NMR characterization and activity of a 21-residue peptide fragment of bacteriocin AS-48 containing its putative membrane interacting region.
    Jiménez MA; Barrachi-Saccilotto AC; Valdivia E; Maqueda M; Rico M
    J Pept Sci; 2005 Jan; 11(1):29-36. PubMed ID: 15635724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure and site-directed mutagenesis of circular bacteriocin plantacyclin B21AG reveals cationic and aromatic residues important for antimicrobial activity.
    Gor MC; Vezina B; McMahon RM; King GJ; Panjikar S; Rehm BHA; Martin JL; Smith AT
    Sci Rep; 2020 Oct; 10(1):17398. PubMed ID: 33060678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the membrane interaction mechanism and antibacterial properties of chensinin-1b.
    Sun Y; Dong W; Sun L; Ma L; Shang D
    Biomaterials; 2015 Jan; 37():299-311. PubMed ID: 25453959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of antibacterial action of dermaseptin B2: interplay between helix-hinge-helix structure and membrane curvature strain.
    Galanth C; Abbassi F; Lequin O; Ayala-Sanmartin J; Ladram A; Nicolas P; Amiche M
    Biochemistry; 2009 Jan; 48(2):313-27. PubMed ID: 19113844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes.
    Wieprecht T; Dathe M; Beyermann M; Krause E; Maloy WL; MacDonald DL; Bienert M
    Biochemistry; 1997 May; 36(20):6124-32. PubMed ID: 9166783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering antimicrobial peptides with improved antimicrobial and hemolytic activities.
    Zhao J; Zhao C; Liang G; Zhang M; Zheng J
    J Chem Inf Model; 2013 Dec; 53(12):3280-96. PubMed ID: 24279498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-bacteria interactions using engineered surface-immobilized peptides from class IIa bacteriocins.
    Etayash H; Norman L; Thundat T; Kaur K
    Langmuir; 2013 Mar; 29(12):4048-56. PubMed ID: 23445325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes.
    Dathe M; Schümann M; Wieprecht T; Winkler A; Beyermann M; Krause E; Matsuzaki K; Murase O; Bienert M
    Biochemistry; 1996 Sep; 35(38):12612-22. PubMed ID: 8823199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and importance of the dimer interface of human calcium-activated nucleotidase.
    Yang M; Horii K; Herr AB; Kirley TL
    Biochemistry; 2008 Jan; 47(2):771-8. PubMed ID: 18067325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plantaricin A is an amphiphilic alpha-helical bacteriocin-like pheromone which exerts antimicrobial and pheromone activities through different mechanisms.
    Hauge HH; Mantzilas D; Moll GN; Konings WN; Driessen AJ; Eijsink VG; Nissen-Meyer J
    Biochemistry; 1998 Nov; 37(46):16026-32. PubMed ID: 9819195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of a bacteriocin produced by Lactobacillus paracasei HL32.
    Pangsomboon K; Bansal S; Martin GP; Suntinanalert P; Kaewnopparat S; Srichana T
    J Appl Microbiol; 2009 Jun; 106(6):1928-40. PubMed ID: 19245409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AS-48 bacteriocin: close to perfection.
    Sánchez-Hidalgo M; Montalbán-López M; Cebrián R; Valdivia E; Martínez-Bueno M; Maqueda M
    Cell Mol Life Sci; 2011 Sep; 68(17):2845-57. PubMed ID: 21590312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
    Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
    J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into enterocin CRL35: mechanism of action and immunity revealed by heterologous expression in Escherichia coli.
    Barraza DE; Ríos Colombo NS; Galván AE; Acuña L; Minahk CJ; Bellomio A; Chalón MC
    Mol Microbiol; 2017 Sep; 105(6):922-933. PubMed ID: 28692133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.